Cellular immunotherapy can alleviate complications after radiotherapy for prostate cancer

Radiotherapy is one of the treatments for prostate cancer, but it can easily cause some complications. Cell immunotherapy can reduce the occurrence of complications during radiotherapy. Let the experts explain cell immunotherapy to you.

80% to 90% of stage AB prostate cancer can be controlled by external irradiation. Failure is often due to metastasis, 10% is due to ineffective local irradiation, and 25% to 30% has both distant metastasis and local ineffectiveness. 70% of those treated with radiotherapy are tumor-free within 24 months and 5 years. The highest survival rate is 80% in stage B and 56% in stage C. Statistics show that patients with tumors invading the rectum, bladder pelvic wall, and ureter have survived cancer-free for more than 3 years. Radiotherapy can relieve metastatic bone pain, but all of these must be combined with cellular immunotherapy.

In view of the many side effects of radiotherapy, if radiotherapy is combined with cellular immunotherapy, these side effects can be effectively alleviated, the patient's pain can be relieved, the body's immunity can be improved, and the cure rate can be improved. Cellular immunotherapy is a method of using biotechnology and biological agents to culture and amplify immune cells collected from the patient's body in vitro and then return them to the patient's body to stimulate and enhance the body's own immune function, thereby achieving the purpose of treating tumors.

The above content is what experts introduced to everyone, that cell immunotherapy can reduce complications after prostate cancer radiotherapy. I hope the above content can be helpful to you. If you have other questions about cell immunotherapy, please consult online experts, who will give you detailed answers.

For more information, please visit the prostate cancer special page at http://www..com.cn/zhongliu/qlx/ or consult an expert for free. The expert will then provide detailed answers to the patient or family based on the patient's specific situation.